Botulinum Toxin Injection for Preventing Secondary Atrial Fibrillation in Patient With Supra-ventricular Tachyarrythmias
| Status: | Recruiting |
|---|---|
| Conditions: | Atrial Fibrillation, Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 18 - 70 |
| Updated: | 4/21/2016 |
| Start Date: | June 2013 |
| End Date: | February 2016 |
| Contact: | Evgeny Pokushalov, MD, PhD |
| Email: | e.pokushalov@gmail.com |
| Phone: | +79139254858 |
The investigators have conducted a prospective, double-blind, randomized study to assess the
comparative safety and efficacy of two different ablation strategies, RFA versus RFA plus
botulinum toxin injection, in patients with supra-ventricular tachyarrhythmias. Results were
assessed with the use of an implanted monitoring device (IMD).
comparative safety and efficacy of two different ablation strategies, RFA versus RFA plus
botulinum toxin injection, in patients with supra-ventricular tachyarrhythmias. Results were
assessed with the use of an implanted monitoring device (IMD).
Inclusion Criteria:
- atrial flutter, AV nodal re-entry tachycardia, focal atrial tachycardia, WPW syndrome
- secondary atrial fibrillation
Exclusion Criteria:
- congestive heart failure
- LV ejection fraction < 35%
- left atrial diameter > 60 mm
We found this trial at
2
sites
Novosibirsk, 63005
Principal Investigator: Evgeny Pokushalov, MD, PhD
Phone: +79139254858
Click here to add this to my saved trials
University of Rochester The University of Rochester is one of the country's top-tier research universities....
Click here to add this to my saved trials